We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

COV:EURONEXT PARISCovivio SA Analysis

Data as of 2026-03-14 - not real-time

$17.45

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The ETF trades at $17.45, just above its calculated support of $17.28, with a 30‑day volatility of about 13.6% and a beta of 0.79, indicating modest market sensitivity. Dividend yield remains exceptionally high at 11.62%, supporting its income appeal, while the trailing P/E of 33 suggests a price level that is roughly fair for a covered‑call strategy. Technical signals are mixed: the RSI sits at 44 (neutral) and the MACD histogram is negative, flagging a bearish tilt, yet the volume trend is increasing and the Fear & Greed Index reads 72.88 (Greed), pointing to short‑term bullish sentiment. Overall, the fund offers a strong current income stream but caps upside potential due to its covered‑call mandate.
Given the neutral to slightly bearish technical backdrop, a valuation that leans toward fair, and the concentration in the tech‑heavy NASDAQ‑100, the ETF carries medium‑to‑high sector risk. The high dividend may be challenging to sustain over prolonged market stress, while liquidity appears solid and regulatory risk low. Investors seeking steady yield with limited beta exposure may find it appropriate for a hold‑or‑buy stance, but should monitor the underlying market’s direction and the fund’s distribution policy.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • High 11.62% dividend yield
  • Price near support level
  • Increasing volume despite bearish MACD

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained income distribution
  • Moderate beta (0.79) and volatility (13.6%)
  • Neutral technical indicators

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Income‑focused strategy with capped upside
  • Sector concentration risk in NASDAQ‑100
  • Low regulatory and liquidity risk

Key Metrics & Analysis

Financial Health

P/E Ratio33.0

Technical Analysis

TrendNeutral
RSI44.1
Support$17.28
Resistance$17.78
MA 20$17.59
MA 50$17.69
MA 200$17.18
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeFair
TypeValue
Dividend Yield11.62%

Risk Assessment

Beta0.79
Volatility13.60%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.